Donald E. Slaughter
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Drug-Induced Hepatotoxicity and Protection
- Toxicology top 10%
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
- Pharmacological Effects of Natural Compounds 1
-
- Ion channel regulation and function 1
- Co-authors
- Robert P. Hanzlik (3 shared papers)Kamlesh P. Vyas (6 shared papers)Byron H. Arison (3 shared papers)Thomayant Prueksaritanont (2 shared papers)Lynn M. Gorham (2 shared papers)Lida Liu (1 shared paper)Bennett Ma (1 shared paper)Xiaoming Yu (1 shared paper)
- Journals
- The Journal of Clinical Pharmacology (2 papers)Drug Metabolism and Disposition (2 papers)Analytical Biochemistry (1 paper)The Journal of Organic Chemistry (1 paper)SLAS DISCOVERY (1 paper)
- Partner nations
- United States
In The Last Decade
Donald E. Slaughter
12 papers receiving 560 citations
Peers
Comparison fields: 5 of 84
- Pharmacology 206
- Pharmacology 83
- Toxicology 17
- Oncology 115
- Biochemistry 29
Countries citing papers authored by Donald E. Slaughter
This map shows the geographic impact of Donald E. Slaughter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald E. Slaughter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald E. Slaughter more than expected).
Fields of papers citing papers by Donald E. Slaughter
This network shows the impact of papers produced by Donald E. Slaughter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald E. Slaughter. The network helps show where Donald E. Slaughter may publish in the future.
Co-authors
The 25 scholars most cited alongside Donald E. Slaughter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s. | 1997 | 244 |
| 2 | 2003 | 86 | |
| 3 | 1991 | 57 | |
| 4 | Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitor. | 2001 | 47 |
| 5 | 1999 | 32 | |
| 6 | 1990 | 30 | |
| 7 | 2000 | 28 | |
| 8 | 1993 | 23 | |
| 9 | 2001 | 13 | |
| 10 | 2003 | 11 | |
| 11 | 2000 | 9 | |
| 12 | Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs. | 1998 | 4 |
About Donald E. Slaughter
Donald E. Slaughter is a scholar working on Pharmacology, Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine and Physiology, having authored 12 papers that have together received 584 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Sympathectomy and Hyperhidrosis Treatments (2 papers), Cardiac electrophysiology and arrhythmias (2 papers), Migraine and Headache Studies (2 papers), Eicosanoids and Hypertension Pharmacology (1 paper), Pharmacological Effects of Natural Compounds (1 paper), Heparin-Induced Thrombocytopenia and Thrombosis (1 paper) and Ion channel regulation and function (1 paper). The work is most often cited by research in Pharmacology (206 citations), Pharmacology (83 citations), Toxicology (17 citations), Oncology (115 citations) and Biochemistry (29 citations). Donald E. Slaughter has collaborated with scholars based in United States. Frequent co-authors include Robert P. Hanzlik, Kamlesh P. Vyas, Byron H. Arison, Thomayant Prueksaritanont, Lynn M. Gorham, Lida Liu, Bennett Ma, Xiaoming Yu, Magang Shou and A. David Rodrigues. Their work appears in journals such as The Journal of Clinical Pharmacology, Drug Metabolism and Disposition, Analytical Biochemistry, The Journal of Organic Chemistry and SLAS DISCOVERY.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.